(5R)-5-[[4-[2-(5-ethyl-1-oxidopyridin-1-ium-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione


Chemical Name: (5R)-5-[[4-[2-(5-ethyl-1-oxidopyridin-1-ium-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
CAS Number: 145350-09-0
Product Number: AG001KTL(AGN-PC-05RCJG)
Synonyms:
MDL No:
Molecular Formula: C19H20N2O4S
Molecular Weight: 372.4381

Identification/Properties


Computed Properties
Molecular Weight:
372.439g/mol
XLogP3:
2.8
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
5
Rotatable Bond Count:
7
Exact Mass:
372.114g/mol
Monoisotopic Mass:
372.114g/mol
Topological Polar Surface Area:
106A^2
Heavy Atom Count:
26
Formal Charge:
0
Complexity:
496
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
N/A
Signal Word:
UN#:
-
Hazard Statements:
-
Precautionary Statements:
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Pioglitazone N-oxide, a key intermediate in pharmaceutical synthesis, plays a vital role in the production of pioglitazone, a widely-used medication for the treatment of type 2 diabetes. As an important chemical compound, Pioglitazone N-oxide serves as a precursor in the synthesis of pioglitazone through various organic reactions. Its versatility and reactivity make it a valuable tool in the pharmaceutical industry for the efficient and controlled synthesis of pioglitazone. Additionally, Pioglitazone N-oxide can be utilized in research and development initiatives aimed at exploring new drug candidates and understanding the biological mechanisms underlying diabetes and related metabolic disorders. Its significance in chemical synthesis lies in its ability to facilitate the production of pioglitazone and other related compounds with potential therapeutic benefits.